MC
RMD icon

Maverick Capital’s ResMed RMD Stock Holding History

Maverick Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,909
Closed -$378K – 436
2024
Q1 		$378K Buy
+1,909
New +$350K 0.01% 290
2023
Q4 		– Sell
-5,891
Closed -$871K – 440
2023
Q3 		$871K Buy
5,891
+2,185
+59% +$395K 0.02% 134
2023
Q2 		$810K Buy
3,706
+2,277
+159% +$507K 0.02% 180
2023
Q1 		$313K Buy
+1,429
New +$310K 0.01% 406
2019
Q4 		– Sell
-57,354
Closed -$7.75M – 409
2019
Q3 		$7.75M Buy
+57,354
New +$7.51M 0.11% 79
2018
Q4 		– Sell
-38,120
Closed -$4.4M – 291
2018
Q3 		$4.4M Sell
38,120
-10,690
-22% -$1.17M 0.05% 179
2018
Q2 		$5.06M Buy
+48,810
New +$4.94M 0.06% 175

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maverick Capital's RMD Position: Q2 2024 in Review

Maverick Capital sold out of ResMed (RMD) in Q2 2024, closing a stake of 1,909 shares — an estimated $378K sold.

Maverick Capital first reported a position in RMD in Q2 2018 and held it in 7 quarters. The position peaked at $7.75M in Q3 2019. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Maverick Capital reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Maverick Capital sold 1,909 ResMed shares in Q2 2024, an estimated $378K.
  • Maverick Capital first reported a position in ResMed in Q2 2018 and held it in 7 quarters.
  • Maverick Capital's ResMed position peaked at $7.75M in Q3 2019.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Maverick Capital's 13F filing for Q2 2024, filed 14 Aug 2024.